期刊文献+

蒙古族人群病原体感染与高血压患病关系 被引量:2

Relationship between pathogenic infection and hypertension in Mongolian
原文传递
导出
摘要 目的探讨肺炎衣原体、肺炎支原体、幽门螺旋杆菌和柯萨奇病毒感染与高血压的关系。方法在蒙古族人群高血压现况研究基础上,选择767例高血压患者和762名血压正常者,进行病例对照研究;对研究对象有关危险因素进行问卷调查和身体指标测量,进行血脂、血糖、肺炎衣原体、肺炎支原体、幽门螺旋杆菌和柯萨奇病毒IgG抗体检测。结果病例组肺炎衣原体(40.6%)、肺炎支原体(18.3%)、幽门螺旋杆菌(56.3%)和柯萨奇病毒(41.4%)IgG抗体阳性率均分别高于对照组肺炎衣原体(36.8%)、肺炎支原体(18.0%)、幽门螺旋杆菌(53.0%)和柯萨奇病毒(40.9%)IgG抗体阳性率,但差异均无统计学意义(P>0.05);在调整心血管危险因素后,肺炎衣原体、肺炎支原体、幽门螺旋杆菌和柯萨奇病毒感染对高血压患病危险性影响差异均无统计学意义。结论肺炎衣原体、肺炎支原体、幽门螺旋杆菌、柯萨奇病毒感染与高血压危险性无明显关联。 Objective To explore the relationship between Chlamydia pneumoniae(CP),Mycoplasma pneumonia(MP),Helicobacter pylori(HP) and Coxsackie virus(CV) infection and hypertension.Methods On the basis of prevalence survey for hypertension in a Mongolian population,767 hypertensives and 762 normotensives were selected as subjects to conduct a case-control study.The body indexes of the subjects were measured,and blood lipid,blood glucose,IgG antibo-dies of CP,MP,HP,and CV were examined for all subjects.Results The positive rates of IgG antibodies of CP(40.6%),MP(18.3%),HP(56.3%),and CV(41.4%) in the cases were higher than the positive rates of IgG antibodies of CP(36.8%),MP(18.0%),HP(53.0%),and CV(40.9%) in the controls.But the differences were not statistically significant(P0.05).After adjustment for confounding factors,ORs of hypertension related to CP,MP,HP,and CV infection were not statistically significant(P0.05).Conclusion CP,MP,HP,and CV infections are not associated with hypertension.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第3期295-296,共2页 Chinese Journal of Public Health
基金 国家自然科学基金(30471484)
关键词 高血压 病原体感染 危险因素 hypertension pathogenic infection fisk factor
  • 相关文献

参考文献11

  • 1Hilgers KF. Monocytes/macrophages in hypertension[ J ]. J Hypertens ,2002,20 (4) :593 - 596.
  • 2Nakanishi N, Sato M, Shirai K, et al. White blood cell count as risk factor for hypertension: a study of Japanese male office workers [ J]. J Hypertens ,2002,20(5) :851 - 857.
  • 3Galeen FX. Cell adhesion in hypertension :endothelial markers of vascular injury and predictors of target organ damage? [ J]. J Hypertens. 2002,20:813 - 816.
  • 4Saikku P, Leinonen M, Mattila K, el al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction[ J]. Lancet, 1988, 2 (8618) :983 -986.
  • 5Cook PJ, Lip GY, Davies P, et al. Chlamydia pneumoniae antibodies in severe essential hypertension [ J ]. Hypertension, 1998,31 : 589 - 594.
  • 6中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3286
  • 7Harvey R, Lane A, Murray L, et al. Effect of Helicobacter pylori infection on blood pressure:a community based cross sectional study[J]. BMJ ,2001, 323 (7307) :264 - 265.
  • 8Momiyama Y, Ohmori R, Taniguchi H, et al. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection[ J]. Atheroslerosis,2004, 9:139 -144.
  • 9Siscovick DS,Schwartz SM,Corey L,el al. Chlamydia pneumoniae, herpes simplex virus type 1, and Cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study [ J ]. Circulation,2000,102 (19) :2335 - 2340.
  • 10Nishimura M, Ushiyama M, Nanbu A, et al. Inverse association of Chlamydia pneumoniae infection with high blood pressure in Japanese adults[ J]. Am J Hypertens ,2001,14:20 - 26.

二级参考文献22

  • 1张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 2Danesh J, Collins R, Peto R. Chronic infection and coronary heart disease: is there a link? Lancet,1997,350:430-436.
  • 3Davidson M,Kuo CC,Middaugh JP,et al. Confirmed previous infection with chlamydia pneumoniae(TWAR) and its presence in early coronary atherosclerosis. Circulation, 1998, 98:628-633.
  • 4Saikku P, Leinonen M, Mattila gJ, et al. Serological evidence of an association of novel chlamydial, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988. 29:983-985.
  • 5Thom DH, Grayston JT,Siscovick DS,et al. Association of prior infection with chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA, 1992,268:68-72.
  • 6Roivainen M, Kajander MV, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation, 2000,101:252-257.
  • 7Ericson K, Salden GP, Lindquist O, et al. Relationship of chlamydia pnemoniae infection to severity of human coronary atherosclerosis. Circulation, 2000,101:2568-2571.
  • 8Ramirez JA,and the Chlamydia pneumoniae/Atherosclerosis study group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med, 1996,125:978-982.
  • 9Rothstein NM, Quinn TC, Madico G, et al. Effect of azithromycin on murine arteriosclerosis exacerbated by chylamydia pneumoniae. J Infect Dis, 2001.183:232-238.
  • 10Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azitheromycin prevents it in a rabbit model. Circulation,1998,97: 633-636.

共引文献3289

同被引文献33

引证文献2

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部